 |
| Covaxin not approved in US |
SHORT SUMMARY
Bharath Bio-tech india made a co-vaccine vaccination which fight against covid-19.WHO has not give approval for co-vaccine.Despite but get approval in India. In recent days ago Bharth BiO -tech ask a suggestion of approval for emergency use was rejected by US. Why the approval was rejected? allow us to see.
.
 |
| Covaxin not approved by WHO |
Bharat Biotech International Limited (BBIL) is an Indian multianational biotechnilogy company headquarters in Hyderbad, engaged within the drug discovery, drug development, manafacture if vaccines, bio -therapeutics, pharmaceuticals qnd healthcare products. And now it made a "Co-vaccine" For fight against corno virus disease wasn't approval for emergency use in us by the country 's top public health regulator the Food and Drug administration (FAD) in US. The US Food and drug Administration has reject the appliance for emergency use isn't allowed because FDA asked more data for clinical trails. But co-vacine has only approved 2 clinical trails . The third clinical trails has not conducted. Even WHO has also not yet approved
The US Food and administration (FAD) has asked for extra information and data on Bharth bio-tech co -vaccine . Co-vaccines has been facing tons of critism on range in India for not sharing phase 3 trail data however indiai's Drug controller general of India(DCRI) gave a approval for co-vaccine in India six month ago. The recongization of WHO aproval get only after the three phase of trail the company would export the drugs to other countries. However we've a still belive third trial phase will submitted in july. said MEA spokesperson Arindam Bagchi at an internet briefing on Thursday, speaking on the matter.